Previous close | 96.50 |
Open | N/A |
Bid | 107.00 |
Ask | 111.50 |
Strike | 300.00 |
Expiry date | 2025-01-17 |
Day's range | 96.50 - 96.50 |
Contract range | N/A |
Volume | |
Open interest | N/A |
The transaction was reported in a recent SEC Filing. Following this transaction, the insider now owns 62,288 shares of Penumbra Inc. Penumbra Inc is a healthcare company focused on developing innovative medical devices.
Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the second quarter 2024 after market close on Tuesday, July 30, 2024 at 4:30 PM Eastern Time. A press release with second quarter 2024 financial results will be issued after market close that day.
Key Insights Using the 2 Stage Free Cash Flow to Equity, Penumbra fair value estimate is US$210 Current share price of...